Literature DB >> 24865816

Decreased Vβ8.2 T-cells in neonatal rats exposed prenatally to Staphylococcal enterotoxin B are further deleted by restimulation in an in vitro cultured thymus.

Wen-Xuan Yang1, Xiang Zhu1, Feng-Ling Yu1, Tao Zhang1, Na Lin1, Ting-Ting Liu1, Fang-Fang Zhao1, Yong Liu1, Hui Xia1, Jun-Chang Guan1.   

Abstract

Staphylococcal enterotoxin B (SEB) administration during adulthood can cause the anergy or deletion of variable portion of the ? chain (V?)?expressing T cells. However, the effect of maternal SEB administration during pregnancy on the thymocytes of neonatal rats remains to be elucidated. In the present study, pregnant rats at gestational day 16 were intravenously injected with 15 µg SEB. The present study revealed that prenatal exposure of SEB significantly increased the proportion of cluster of differentiation (CD)4?single positive (SP) T cells and decreased the proportions of CD8?SP, CD4+ V?8.2+ and CD8+ V?8.2+ T cells in the thymus of neonatal rats between day 0 and 5 after delivery. In an in vitro cultured thymus, SEB restimulation significantly increased the proportion of double positive cells and decreased the proportions of CD4?SP, CD8?SP, CD4+ V?8.2+ and CD8+ V?8.2+ T cells. Furthermore, the decreased V?8.2+ T?cells in neonatal rats exposed prenatally to SEB were further deleted by SEB restimulation in an in vitro cultured thymus. These data suggested the special response pattern of the remaining SEB?specific T cells to SEB restimulation in neonatal rats exposed prenatally to SEB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24865816     DOI: 10.3892/mmr.2014.2270

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  1 in total

1.  Staphylococcal enterotoxin B administration in pregnant rats alters the splenic lymphocyte response in adult offspring rats.

Authors:  Ping Zhou; Xin-Sheng Zhang; Zhi-Ben Xu; Shu-Xian Gao; Qing-Wei Zheng; Ming-Zhu Xu; Lin Shen; Feng Yu; Jun-Chang Guan
Journal:  BMC Microbiol       Date:  2017-01-03       Impact factor: 3.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.